Amazon Recalls Over 112,000 Bottles of Acetaminophen Over Discolored Pills
Published:
Image credit: Benjah-bmm27 · Public domain · Wikimedia Commons
In brief
Aurobindo Pharma USA has voluntarily recalled 112,932 bottles of Amazon Basic Care Extra Strength Acetaminophen sold nationwide through Amazon after customers reported discolored caplets. The recall, covering seven lot numbers across 200-, 500- and 1,000-count bottles, began September 18, 2026, and the FDA has not yet assigned it a risk classification.
What is being recalled
Aurobindo Pharma USA Inc. has recalled 112,932 bottles of 500-milligram Amazon Basic Care Extra Strength Acetaminophen caplets sold nationwide through Amazon, according to Hoodline and Local 12, both of which cite the manufacturer's recall notice. The caplets were manufactured in India by Aurobindo Pharma Limited and distributed by Amazon.com Services LLC, Local 12 reported.
The recall covers three bottle sizes: 90,456 bottles of 500-count packs, 14,640 bottles of 200-count packs, and 7,836 bottles of 1,000-count packs, per figures reported by Hoodline.
Why the recall was issued
Aurobindo initiated the voluntary recall on September 18, 2026, after receiving consumer complaints about discolored tablets, Hoodline and Local 12 reported. Neither outlet described injuries linked to the discoloration, and medical health-news site MedShadow Foundation likewise reported no injuries associated with the recall as of its report.
Recalled lot numbers by bottle size
Bottle size
Lot number(s)
Expiration date
200-count
ACD125040A
09/30/2027
500-count
ACD124036A, ACD124030A
09/30/2027
500-count
ACD124042A
10/31/2027
500-count
ACD124048B
11/30/2027
500-count
ACD125010A
02/29/2028
1,000-count
ACD124048A
11/30/2027
FDA status and a prior recall
As of the reports from Hoodline and Local 12, the Food and Drug Administration had not yet assigned a risk classification to the recall. Hoodline reported that a separate, earlier recall of 4,608 bottles of Amazon's 325-milligram acetaminophen in 2025, triggered by reports of a 'brown surface' on tablets, was later classified by the FDA as Class II, a category the agency uses when a product may cause temporary or reversible health effects. Local 12 also reported that 4,608 bottles were recalled in 2025 over discoloration, without using that specific wording.
What consumers should do
Check the NDC number, UPC, lot number and expiration date printed on the bottle against the recalled lot numbers listed above, as advised by Hoodline and Local 12.
Contact a pharmacist or healthcare provider with questions about an affected bottle, per guidance cited in both reports.
Note that the affected product was distributed nationwide through Amazon.com Services LLC, according to Local 12.
Questions
What product is affected by the recall?
Amazon Basic Care Extra Strength Acetaminophen, 500-milligram caplets sold in 200-count, 500-count and 1,000-count bottles through Amazon, according to Hoodline and Local 12.
How many bottles were recalled?
112,932 bottles in total: 90,456 of the 500-count size, 14,640 of the 200-count size, and 7,836 of the 1,000-count size, per Hoodline's report.
Why was the acetaminophen recalled?
Aurobindo Pharma USA recalled the product after consumers reported discolored tablets, according to Hoodline, Local 12 and MedShadow Foundation. None of the reports described confirmed injuries.
Has the FDA classified the health risk?
As of the available reports, the FDA had not yet assigned a risk classification to this recall, though a similar 2025 Amazon acetaminophen recall was later classified Class II, Hoodline reported.
Has Amazon-brand acetaminophen been recalled before?
Yes. Hoodline and Local 12 reported that Aurobindo recalled 4,608 bottles of Amazon's 325-milligram acetaminophen in 2025 after consumers reported discoloration, which Hoodline described as a 'brown surface' on the tablets.
This piece was prepared with artificial intelligence and passed an automated source check before publication. If you see an error, ask for a correction. Request a correction or reply · How we make this
Major health authorities, including the U.S. CDC and the World Health Organization, recommend adults get at least 150 minutes of moderate-intensity aerobic activity a week; the CDC also recommends muscle-strengthening work on two or more days. For beginners, guidance from the CDC and the Mayo Clinic points to starting slowly, warming up before and cooling down after each session, and increasing activity by roughly 10% a week rather than all at once.
A hormonal intrauterine device (IUD) releases the progestin levonorgestrel directly into the uterus, which thins the uterine lining and can reduce endometriosis-related pain and bleeding. Clinical guidelines list it as a second-line hormonal option, and studies report pain scores falling significantly within a year, with benefits lasting up to a decade in some patients, though the device is not a cure.
A France Télévisions documentary airing this week has revived scrutiny of hormone drugs — led by the anti-androgen Androcur (cyproterone acetate) — over their link to meningioma brain tumors. France's medicines agency ANSM has warned since 2018 that the risk rises sharply with dose and duration, and has tightened prescribing rules, though the drugs remain legally sold.
At least 13 people in Spain have developed salmonellosis after eating eggs contaminated with Salmonella Enteritidis, according to a European food-safety alert Spanish authorities filed on October 8, 2026. The eggs, produced in Spain, were also distributed to Portugal before being withdrawn from the market.
